Progestogen only Injectable Contraceptives (POIC)

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://hl7.org/fhir/sid/icd-10-cm",
      "filter" : [ {
        "property" : "concept",
        "value" : "Z30.013",
        "op" : "is-a"
      } ],
      "version" : "2023"
    }, {
      "system" : "http://hl7.org/fhir/sid/icd-10-cm",
      "filter" : [ {
        "property" : "concept",
        "value" : "Z30.42",
        "op" : "is-a"
      } ],
      "version" : "2023"
    } ]
  },
  "date" : "2020-08-04T01:00:25-04:00",
  "meta" : {
    "versionId" : "5",
    "lastUpdated" : "2020-08-04T01:00:25.000-04:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "NACHC Steward",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values contains the use of both generic and brand name Progestogen only Injectable Contraceptives (POIC) for contraception.),(Data Element Scope: The intent of this data element is to identify patients who have expressed the use of both generic and brand name Progestogen only Injectable Contraceptives (POIC) for contraception. Using the Quality Data Model, this particular element would map to the \"Medication\" category, with Datatype: \"Medication, Active\".),(Inclusion Criteria: Contraception use that indicates active usage of both generic and brand name Progestogen only Injectable Contraceptives (POIC).),(Exclusion Criteria: There is no exclusion criteria listed for this value set.)",
  "name" : "ProgestogenOnlyInjectableContraceptivesPOIC",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://hl7.org/fhir/sid/icd-10-cm",
      "code" : "Z30.013",
      "display" : "Encounter for initial prescription of injectable contraceptive",
      "version" : "2023"
    }, {
      "system" : "http://hl7.org/fhir/sid/icd-10-cm",
      "code" : "Z30.42",
      "display" : "Encounter for surveillance of injectable contraceptive",
      "version" : "2023"
    } ],
    "offset" : 0,
    "total" : 2,
    "identifier" : "urn:uuid:0ba39ed3-6dfc-4316-9e3d-8c4b5444dff1",
    "timestamp" : "2023-06-29T19:29:47-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Progestogen only Injectable Contraceptives (POIC)",
  "extension" : [ {
    "valueString" : "NACHC Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2020-08-04",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "f3d91d13-0f6f-46fb-a829-79eb449bca4b",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.100",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1221.100"
  } ],
  "version" : "20200804"
}